Apr 8 2011
Cenovus Energy Inc. (TSX, NYSE: CVE) is proud to announce that the company has committed $1.3 million to the Alberta Children's Hospital Foundation to help experts at the Alberta Children's Hospital in the fight against childhood cancer. Cenovus's gift is specifically directed to support the pediatric Blood & Marrow Transplant (BMT) Program.
"With support from the community, our hospital has become recognized nationally for its high success rates in BMT survival and low rates of graft-versus-host disease, a potentially fatal complication from transplant," says Saifa Koonar, President and CEO of the Alberta Children's Hospital Foundation. "This generous gift from Cenovus will help our experts continue to expand and improve the use of BMT for kids with cancer and those with other life-threatening diseases."
"We're extremely pleased to commit $1.3 million to help further the Blood & Marrow Transplant program and increase the survival rate of children fighting cancer,'' said Brian Ferguson, Cenovus President & Chief Executive Officer. "We're heartened by the leading-edge work being done at the hospital by the doctors, nurses, researchers and other staff seeking innovative ways to treat cancer and other serious illnesses. All of us at Cenovus are humbled by the courage of the patients who deal with this every day."
Seven-year-old Hannah Baartman received a life-saving bone marrow transplant five years ago to cure a rare blood disorder. She and her mom, Andrea, personally thanked Brian Ferguson for the support from Cenovus for kids like her. "Finding out that a BMT could save Hannah was an incredible source of hope for us," says Andrea. "And now, this gift from Cenovus is going to provide that same life-saving hope to countless other kids and families."
MRI-guided SBRT reduces side effects in prostate cancer treatment